Australia Nutraceuticals - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The australia nutraceuticals market size was valued at USD 6.22 billion in 2025, is expected to grow to USD 6.52 billion in 2026, and is projected to reach USD 8.27 billion by 2031, registering a compound annual growth rate (CAGR) of 4.85% during the period 2026-2031. This report is Segmented by Product Type (Functional Food, Functional Beverage, and Dietary Supplements), and Distribution Channels (Supermarkets and Hypermarkets, Convenience Stores, Specialty Stores, Online Retail Stores, and Other Distribution Channels). The Market Forecasts are Provided in Terms of Value (USD).

Australia Nutraceuticals Market Trends and Insights

Continued demand for immune-support products

Consumer emphasis on immune health continues to drive the growth of the nutraceuticals market in Australia. Post-pandemic, the focus on preventive health strategies persists, sustaining demand for immune-support supplements such as vitamin C, vitamin D, zinc, elderberry, echinacea, and probiotics. Increased awareness of seasonal illnesses, respiratory health, and overall well-being has led to the widespread adoption of daily immune supplementation across various age groups. Furthermore, advancements in delivery formats, including gummies, effervescent tablets, powders, and functional beverages, have enhanced accessibility and convenience, appealing to younger consumers and those with lifestyle-oriented preferences. As preventive healthcare gains further importance in Australia, immune-support products remain a key growth driver within the nutraceuticals market, creating more opportunities for innovation and market expansion.

Increasing prevalence of chronic diseases such as diabetes

The increasing prevalence of chronic diseases, particularly diabetes, is a key factor driving the growth of the nutraceuticals market in Australia. As lifestyle-related health conditions become more widespread, consumers are increasingly seeking dietary supplements and functional nutrition products to enhance health management and mitigate associated risks. For example, the International Diabetes Federation reported that in 2024, 7.4% of adults were living with diabetes, underscoring the rising burden of metabolic disorders. This growing prevalence is significantly boosting demand for nutraceutical products aimed at blood sugar management, cardiovascular health, weight control, and metabolic balance. Additionally, the adoption of preventive supplementation strategies under medical supervision by individuals with diabetes or pre-diabetic conditions is further driving consistent and sustained product demand, highlighting the critical role of nutraceuticals in proactive health management.

Stringent regulatory framework

A stringent regulatory framework serves as a significant restraint in the Australian nutraceuticals market. Companies are required to enhance their compliance with strict safety, labeling, formulation, and health-claim regulations before commercializing their products. Oversight by authorities such as Food Standards Australia New Zealand (FSANZ), along with complementary therapeutic goods regulations, enforces rigorous standards on ingredient approvals, permissible health claims, contaminant limits, and advertising practices. These regulations often extend product development timelines and increase compliance costs, particularly for smaller manufacturers and new entrants. Additionally, frequent updates to ingredient standards, novel food approvals, and the need for evidence-based substantiation of functional claims may require reformulation or further clinical validation, delaying market entry.

Other drivers and restraints analyzed in the detailed report include:

• Popularity of plant-based and vegan nutraceuticals
• Surge in sports nutrition and performance-enhancing supplements
• Complex ingredient approval and reformulation risks
• Product Shelf-Life and Storage Requirements Limiting Distribution Channels

Segment Analysis

Dietary supplements accounted for 48.87% of the total market share in 2025, emerging as the leading category due to their integration into daily health routines and preventive healthcare practices. This position is supported by sustained consumer demand for vitamins, minerals, herbal supplements, probiotics, omega-3 fatty acids, and condition-specific formulations targeting areas such as immunity, bone health, heart health, digestive wellness, sleep, and cognitive function. Regulatory oversight by the Therapeutic Goods Administration enhances consumer confidence in listed (AUST L) products, fostering trust and encouraging repeat purchases. Growing awareness of micronutrient deficiencies, lifestyle-related health concerns, and the increasing focus on immune resilience continue to drive consistent growth in this category.

Functional beverages are projected to grow at a CAGR of 5.65% through 2031, reflecting a rising consumer preference for convenient, ready-to-consume wellness solutions that combine nutrition with functionality. This segment includes fortified drinks, protein beverages, and probiotic drinks that address needs such as immunity, hydration, gut health, cognitive performance, and sports recovery. Increasing demand for on-the-go nutrition, clean-label formulations, and reduced-sugar or naturally sweetened beverages is driving product innovation. The shift away from traditional carbonated soft drinks toward health-oriented alternatives further supports growth in this category. Additionally, advancements in ingredient technologies, such as stable probiotics, plant-based proteins, adaptogens, and nootropic compounds, are enabling manufacturers to deliver clinically relevant benefits in beverage formats.

Complete Report Scope:

• By Product Type
  • Functional Food
    • Cereals
    • Bakery and Confectionery
    • Dairy
    • Snacks
    • Other Functional Foods
  • Functional Beverage
    • Energy Drinks
    • Sports Drinks
    • Fortified Juice
    • Dairy and Dairy-Alternative Beverages
    • Other Functional Beverages
  • Dietary Supplements
    • Vitamins and Minerals
    • Botanicals
    • Enzymes
    • Fatty Acids
    • Proteins
    • Other Dietary Supplements
• By Distribution Channel
  • Supermarkets and Hypermarkets
  • Convenience Stores
  • Specialty Stores
  • Online Retail Stores
  • Other Distribution Channels

List of Companies Covered in this Report:

• Herbalife Nutrition Ltd.
• General Mills, Inc.
• PepsiCo, Inc.
• Nestle S.A.
• Haleon plc
• Remedy Drinks
• Frucor Suntory Australia Pty Ltd
• Health & Happiness (H&H) Group
• Pharmacare Laboratories Pty Ltd
• Bayer Australia Ltd
• Pure Harvest Pty Ltd
• Blackmores Limited
• Swisse Wellness Pty Ltd
• Star Combo Pharma Ltd
• Vitaco Health Group Ltd
• Melrose Health Group Ltd
• The Chia Co
• Body Science International
• Nutritional Growth Solutions
• Nature's Care Manufacture Pty Ltd

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support